Mightypirate, I have no information on production details of the various plant extracts that are incorporated. The company has been incorporating these for quite some time now and I can only assume that they are very much aware of the source availability and have planned correspondingly.
With regard to the supplementary monoterpenoid/monoterpene(s), the specific compounds that are now being added are not identified within the patent documents however the basic structure types that are disclosed there would not be expected to meet major source problems.
Evolis Ingredients, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable